Kimura Mai, Ishii Ikuya, Baba Asami, Takara Tsuyoshi
YAWATA CORPORATION, Yonago, Tottori, Japan.
ORTHOMEDICO Inc., Bunkyo-ku, Tokyo, Japan.
Nutr Health. 2024 Jul 23:2601060241265389. doi: 10.1177/02601060241265389.
Saw palmetto extract (SPE) is the most commonly used supplement for the treatment of lower urinary tract symptoms (LUTS), but most evidence is for those with LUTS, and little data is verifying its effectiveness for those who do not have the disease but are troubled by symptoms. The purpose of this study was to examine the effect of SPE on the improvement of urinary frequency problems that present stress due to urinary urgency in daily life, among healthy Japanese adults aged ≥50 years who are not diagnosed with benign prostatic hyperplasia or overactive bladder. They were randomly assigned to the SPE group or placebo group (34 participants per group) using a computerized random number generator. Each participant was instructed to take one capsule containing SPE (320 mg) or placebo every day for 12 weeks. Subjective symptoms were assessed using the overactive bladder questionnaire, and the score of symptom bother by frequent urination during the daytime hours was set as the primary outcome. The other outcomes were subjective urinary symptoms and urinary frequencies. The final efficacy analysis dataset was per protocol set, and 33 participants in each group were analyzed. After SPE intervention for 12 weeks, the score of symptom bother by frequent urination during the daytime hours was significantly improved and the daytime frequency of urination assessed using the urinary log was significantly decreased. The consumption of SPE improved urinary frequency-related quality of life such as bother of urinary symptoms in healthy Japanese adults (UMIN000045334).
锯叶棕提取物(SPE)是治疗下尿路症状(LUTS)最常用的补充剂,但大多数证据是针对患有LUTS的人群,而对于那些没有疾病但受症状困扰的人,几乎没有数据证实其有效性。本研究的目的是在未被诊断为良性前列腺增生或膀胱过度活动症的≥50岁健康日本成年人中,研究SPE对改善因尿急在日常生活中造成压力的尿频问题的效果。使用计算机随机数生成器将他们随机分为SPE组或安慰剂组(每组34名参与者)。每位参与者被指示每天服用一粒含有SPE(320毫克)或安慰剂的胶囊,持续12周。使用膀胱过度活动症问卷评估主观症状,并将白天因尿频导致的症状困扰评分作为主要结果。其他结果是主观尿路症状和排尿频率。最终疗效分析数据集采用符合方案集,每组分析33名参与者。在进行12周的SPE干预后,白天因尿频导致的症状困扰评分显著改善,使用排尿日志评估的白天排尿频率显著降低。在健康日本成年人中,服用SPE改善了与尿频相关的生活质量,如尿路症状困扰(UMIN000045334)。